| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 199.13B | $ 176.81B | $ 171.34B | $ 156.59B | $ 138.64B |
| Gross Profit | $ 50.90B | $ 49.24B | $ 47.01B | $ 39.95B | $ 35.99B |
| Operating Income | $ 8.11B | $ 8.89B | $ 8.74B | $ 8.45B | $ 8.95B |
| EBITDA | $ 9.66B | $ 10.48B | $ 10.49B | $ 10.13B | $ 10.03B |
| Net Income | $ 5.66B | $ 5.98B | $ 5.99B | $ 5.89B | $ 6.10B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 9.49B | $ 8.29B | $ 6.53B | $ 7.39B | $ 4.88B |
| Total Assets | $ 121.49B | $ 116.89B | $ 108.93B | $ 102.75B | $ 97.46B |
| Total Debt | $ 33.23B | $ 32.70B | $ 26.65B | $ 25.80B | $ 24.89B |
| Net Debt | $ 23.74B | $ 24.41B | $ 20.13B | $ 18.41B | $ 20.01B |
| Total Liabilities | $ 77.47B | $ 75.46B | $ 69.52B | $ 66.42B | $ 61.33B |
| Stockholders' Equity | $ 43.88B | $ 41.31B | $ 39.31B | $ 36.24B | $ 36.06B |
| Cash Flow | |||||
| Free Cash Flow | $ 3.17B | $ 4.55B | $ 6.76B | $ 7.25B | $ 7.28B |
| Operating Cash Flow | $ 4.29B | $ 5.81B | $ 8.06B | $ 8.40B | $ 8.36B |
| Investing Cash Flow | $ -1.34B | $ -5.17B | $ -5.57B | $ -4.56B | $ -9.64B |
| Financing Cash Flow | $ -1.74B | $ 1.19B | $ -3.35B | $ -1.32B | $ 423.00M |
Elevance Health (CH:A58)
:A58
